The effects of androgenic anabolic steroids on cardiac autonomic nervous function in athletes users

The effects of androgenic anabolic steroids on cardiac autonomic nervous function in athletes users - AAS-ANS

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00004536

Enrollment

120

Registered

2012-11-13

Start date

2012-11-25

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiac autonomic dysfunction I51.7

Interventions

Group 1: Power trained athletes-anabolic users will be examined once by echocardiography, tilt-testing and cardiopulmonary exercise testing Group 2: Power trained athletes- non anabolic users will be

Eligibility

Sex/Gender

All

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: power-trained athlete without using drugs, power-trained athletes anabolic users for at least 3 years or sedentary healthy individual

Exclusion criteria

Exclusion criteria: individuals with chronic diseases

Design outcomes

Primary

Measure	Time frame
cardiac autonomic function assessed by baroreflex sensitivity and HRV (heart rate variability) modulation	—

Secondary

Measure	Time frame
cardiac hypertrophy assessed by echocardiography and aerobic capacity assessed by cardiopulmonary testing	—

Countries

Greece

Contacts

Public ContactEvangelia Kouidi

Aristotle University of Thessaloniki

ekouidi@med.auth.gr0030 2310 992189

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026